Cargando…

Individualized immunoglobulin therapy in chronic immune‐mediated peripheral neuropathies*

Despite the well‐recognized importance of immunoglobulin therapy individualization during the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), the pathway to best achieve optimization is unknown. There are many pharmacokinetic and immunobiologic variables that can potentially i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen, Jeffrey A., Berger, Melvin, Querol, Luis, Kuitwaard, Krista, Hadden, Robert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033159/ https://www.ncbi.nlm.nih.gov/pubmed/29573033 http://dx.doi.org/10.1111/jns.12262

Ejemplares similares

Optimizing IgG Therapy in Chronic Autoimmune Neuropathies: A Hypothesis Driven Approach
por: Berger, Melvin, et al.
Publicado: (2015)

Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia
por: Kavanagh, Simon, et al.
Publicado: (2018)

Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency
por: Berger, Melvin
Publicado: (2008)

Immune-Mediated Peripheral Neuropathy in Patients with Diffuse Panbronchiolitis
por: Kang, You-Ri, et al.
Publicado: (2020)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Immunoglobulins as steroid sparing agents in chronic relapsing inflammatory optic neuropathy
por: Gonzalez-Granado, Luis I.
Publicado: (2010)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy
por: Jeter, Ashley, et al.
Publicado: (2012)

Regional differences in cell‐mediated immunity in people with diabetic peripheral neuropathy
por: Pickwell, K., et al.
Publicado: (2019)

Immunoglobulin G4-related disease presenting with peripheral neuropathy: a case report
por: Bong, Jeong Bin, et al.
Publicado: (2021)

Immunoglobulin Use for the Management of Painful Peripheral Neuropathy: A Systematic Review and Meta-Analysis
por: Zis, Panagiotis, et al.
Publicado: (2022)

Autonomic Involvement in Subacute and Chronic Immune-Mediated Neuropathies
por: Mazzeo, Anna, et al.
Publicado: (2013)

Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy
por: De Simoni, Desiree, et al.
Publicado: (2020)

Immunoglobulin G4-related Disease Accompanied by Peripheral Neuropathy: A Report of Two Cases
por: Kawazoe, Tomoya, et al.
Publicado: (2021)

Immune-mediated vincristine-induced neuropathy: Unlocking therapies
por: Savelieff, Masha G., et al.
Publicado: (2021)

Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy
por: Geerts, Margot, et al.
Publicado: (2021)

Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome): a multicenter, double-blind trial
por: Koike, Haruki, et al.
Publicado: (2015)

Peripheral neuropathy from use of linezolid and metronidazole in a pediatric patient
por: McConnell, Athena, et al.
Publicado: (2021)

GAIT UNSTEADINESS AS AN INDICATOR OF COGNITIVE STATUS IN INDIVIDUALS WITH PERIPHERAL NEUROPATHY
por: Kang, Gu Eon, et al.
Publicado: (2019)

Peripheral Nerve Imaging Aids in the Diagnosis of Immune-Mediated Neuropathies—A Case Series
por: Dörner, Marc, et al.
Publicado: (2020)

Autoimmune Inflammatory Neuropathy
por: Hadden, R D M, et al.
Publicado: (1999)

Functional status mediates the association between peripheral neuropathy and health-related quality of life in individuals with diabetes
por: Riandini, Tessa, et al.
Publicado: (2017)

Isotyping paranodal antibodies in inflammatory neuropathies: One step closer to precision care
por: Lleixà, Cinta, et al.
Publicado: (2020)

Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy
por: van der Pol, W.-Ludo, et al.
Publicado: (2010)

Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study
por: Bischof, Antje, et al.
Publicado: (2019)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

A 70-year-old male with peripheral neuropathy, ataxia and antigliadin antibodies shows improvement in neuropathy, but not ataxia, after intravenous immunoglobulin and gluten-free diet
por: Anandacoomaraswamy, Dharshan, et al.
Publicado: (2008)

PERIPHERAL ENTRAPMENT NEUROPATHIES
Publicado: (1964)

Peripheral neuropathy in thalassemia
por: Sawaya, Raja A., et al.
Publicado: (2006)

Diagnosis of peripheral neuropathy
por: Lehmann, Helmar C., et al.
Publicado: (2020)

Orphan Peripheral Neuropathies
por: Finsterer, Josef, et al.
Publicado: (2021)

Immune-Mediated Neuropathies: Pathophysiology and Management
por: Shastri, Abhishek, et al.
Publicado: (2023)

Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy
por: White, Claire M., et al.
Publicado: (2015)

Encephalopathy and Axonal Neuropathy Associated With Mycoplasma Pneumoniae Infection: Response to Intravenous Immunoglobulin Therapy
por: Saker, Ali, et al.
Publicado: (2016)

Pattern of muscle strength improvement after intravenous immunoglobulin therapy in multifocal motor neuropathy
por: Bakers, Jaap N.E., et al.
Publicado: (2021)

Improvement of Gait after 4 Weeks of Wearable Focal Muscle Vibration Therapy for Individuals with Diabetic Peripheral Neuropathy
por: Rippetoe, Josiah, et al.
Publicado: (2020)

Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens
por: Chouksey, Akhilesh, et al.
Publicado: (2005)

Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy
por: Morgenstern, Jakob, et al.
Publicado: (2021)

Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
por: Möhn, Nora, et al.
Publicado: (2019)

A Clinical and Electrophysiological Study of Peripheral Neuropathies in Predialysis Chronic Kidney Disease Patients and Relation of Severity of Peripheral Neuropathy with Degree of Renal Failure
por: Jasti, Dushyanth Babu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1364r964k0jecapssshlilqlgb